General
Preferred name
BENDAMUSTINE HYDROCHLORIDE
Synonyms
EP-3101 ()
SDX-105 (Cytostasane) HCl ()
Bendamustine HCl ()
Ribomustin ()
Treanda ()
IMET 3393 ()
Cytostasan ()
2-Benzimidazolinebutryric acid, 1-methyl-5-bis(2-chloroethyl)amino-, hydrochloride ()
SDX-105 ()
WLN: T56 BN DNJ B1 C3VQ GN2G2G &GH ()
1H-Benzimidazole-2-butanoic acid, 5-[bis(2-chloroethyl)amino]-1-methyl-, monohydrochloride ()
2-Benzimidazolebutyric acid, 5-[bis(2-chloroethyl)amino]-1-methyl-, monohydrochloride ()
Bendamustine (hydrochloride) ()
Bendamustine (SDX105) HCl ()
Cytostasane HCl ()
Vivimusta ()
NSC-138783 ()
Belrapzo ()
Bendeka ()
SYBL-0501 ()
SYB L-0501 ()
P&D ID
PD000102
CAS
3543-75-7
Tags
available
drug
Drug indication
leukaemia
Drug Status
approved
Max Phase
4.0
First approval
2008
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Restores mutant p53 activity
(Tocris Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
12
AdooQ Bioactive Compound Library
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
CZ-OPENSCREEN Bioactive Library
DrugMAP
DrugMAP Approved Drugs
MedChem Express Bioactive Compound Library
NIH Approved Oncology Drugs
Selleckchem Bioactive Compound Library
The Spectrum Collection
Tocris Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
21
Molecular Weight
393.08
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
1
Rotatable Bonds
9
Ring Count
2
Aromatic Ring Count
2
cLogP
3.69
TPSA
58.36
Fraction CSP3
0.5
Chiral centers
0.0
Largest ring
6.0
QED
0.66
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Primary Target
Apoptosis Inducers
Pathway
Apoptosis
Cell Cycle/DNA Damage
Target
DNA alkylator/crosslinker
DNA/RNA Synthesis
Source data